Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent CDI”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Not applicableLooking for participantsNCT07613645
What this trial is testing

Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)

Who this might be right for
Clostridioides Difficile Infection
University of Michigan 20
Not applicableUnknownNCT03964844
What this trial is testing

Clostridium Difficile Infection (CDI) in Hematologic Patients.

Who this might be right for
C.Difficile Diarrhea
Hospital General Universitario Gregorio Marañon 450
Large-scale testing (Phase 3)Study completedNCT01513239
What this trial is testing

MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 1,203
Testing effectiveness (Phase 2)Study completedNCT01398969
What this trial is testing

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
McMaster University 232
Early research (Phase 1)Study completedNCT04891965
What this trial is testing

ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection Recurrence
Adiso Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT03106844
What this trial is testing

The ICON Study: Outcomes After FMT for Patients With IBD and CDI

Who this might be right for
Inflammatory Bowel DiseasesClostridium Difficile Infection
Brigham and Women's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT03617172
What this trial is testing

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Who this might be right for
Clostridium Difficile
Vanderbilt University Medical Center 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Looking for participantsNCT06071312
What this trial is testing

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Who this might be right for
Clostridium DifficileUlcerative Colitis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 64
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Early research (Phase 1)Study completedNCT02865616
What this trial is testing

MET-2 Clinical Study for Recurrent Clostridium Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection
NuBiyota 19
Not applicableStudy completedNCT02214771
What this trial is testing

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Who this might be right for
Clostridium Difficile Infection
Astellas Pharma S.A.S. 296
Post-approval studies (Phase 4)Ended earlyNCT04626947
What this trial is testing

Prevention of Recurrent Clostridium Difficile Infection (CDI) in Patients With Inflammatory Bowel Disease (IBD).

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease+1 more
David Binion, MD 19
Next Page